Guo · EBioMedicine 2023 · Prospective cohort study · n=1318

Trajectories of olfactory identification preceding incident mild cognitive impairment and dementia: a longitudinal study.

Cited 21 times in the scientific literature.

Level 3 - non-randomized controlled study

Prospective longitudinal cohort study with postmortem pathology

PubMed 38251465 · doi:10.1016/j.ebiom.2023.104862 · record verified 2026-08-27

What was done

Within the Rush Memory and Aging Project, 1,318 dementia-free older adults were followed annually for up to 11 years. Olfactory identification was evaluated annually using the Brief Smell Identification Test. Incident mild cognitive impairment (MCI) and dementia diagnoses were tracked in 900 cognitively intact participants. Neuropathological assessments were performed on brain autopsies from 518 participants who died during follow-up. Trajectories were analyzed using mixed-effect models with backward timescales.

What was found

Participants developing MCI had faster olfactory identification decline than those remaining cognitively intact (β = -0.09 [95% CI -0.13, -0.05]), showing significantly lower performance starting 5 years before MCI diagnosis (mean difference at year -5: -0.39 [-0.71, -0.07]). Among participants with incident MCI, those progressing to dementia declined faster than non-progressors (β = -0.19 [-0.36, -0.01]), showing significantly lower scores starting 3 years prior to dementia diagnosis (mean difference at year -3: -0.95 [-1.67, -0.23]). Faster olfactory decline correlated with higher global Alzheimer's pathology, neurofibrillary tangles, and amyloid-beta load.

Why it matters

Accelerated decline in olfactory identification serves as an early behavioral marker appearing years before clinical MCI and dementia diagnoses, linked directly to accumulating Alzheimer's pathology.

Limits

The abstract lacks demographic details (e.g., age, sex, race) and information on whether analyses adjusted for potential confounders such as smoking or sinonasal disease. Autopsy data were limited to participants who died during the follow-up period.

Cited by